United States · 
Who invested in Kimia Therapeutics?
Kimia Therapeutics's investors include Horizons Ventures.
United States · Series A startup
Who invested in Kimia Therapeutics
Funding summaryUpdated 26 Oct 2026
$55Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $55MDec 2023
- Investors
- 1
The rounds
- Dec 2023
Founders and team
From Kimia Therapeutics's own website: 2 founders, 2 on the team.
Stig K. HansenCo-founder & Chief Executive Officer, President
Ray FuciniCo-founder & Sr Director, Discovery Platform Technology
- Melissa PaoloniSenior Vice President of Operations
- Imran HaqueChief Technology Officer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Kimia Therapeutics
How much has Kimia Therapeutics raised?
Kimia Therapeutics has raised $55M across 1 round since 2023.
When did Kimia Therapeutics last raise?
Kimia Therapeutics's most recent round was a Series A of $55M in Dec 2023.
What was Kimia Therapeutics's biggest round?
Its most recent round, $55M in Dec 2023, is also its largest on record.
Who backed Kimia Therapeutics first?
Kimia Therapeutics's first round on record, in Dec 2023, was backed by Horizons Ventures.
What stage is Kimia Therapeutics at?
Kimia Therapeutics's latest named round is a Series A, in Dec 2023.
Where is Kimia Therapeutics based?
Kimia Therapeutics is based in the United States.
Companies like Kimia Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.